|
February 14, 2006 Categories: New articles Posted by admin
In randomized trials in which they are compared with BMS, economic evaluation is advantageous for DES, with good cost-effectiveness ratios for both cost per quality-adjusted life year (QALY) and cost per revascularization avoided.
PubMed abstract
|
|
